相关实验视频

Updated: Jan 9, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

SpaCBA-OVA脂质体重编程免疫耐受性以通过DC-T细胞交叉连接改善过敏性鼻炎

Jinna Yang^1,2, Jinmei Xue³, Lihua Mo¹

¹Department of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.

|December 5, 2025

概括

一种结合益生菌蛋白和卵蛋白的新型脂质体配方有效治疗小鼠过敏性鼻炎 (AR). 这种免疫疗法方法可以增强抗原输送,促进免疫耐受性,并通过重新编程免疫细胞来减少AR症状.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
药物运输药物运输药物运输

背景情况:

过敏性鼻炎 (AR) 是一种常见的免疫疾病,由Th2炎症驱动,目前的治疗只能提供症状缓解.
过敏原特异性免疫疗法 (AIT) 旨在实现长期耐受性,但在粘膜传递,抗原稳定性和有效性方面面临挑战.

研究的目的:

设计和评估一种脂质体配方,同时封装益生菌蛋白 (SpaCBA) 和卵蛋白 (OVA),以改善AR治疗.
在AR的小鼠模型中评估SpaCBA-OVA脂质体的免疫调节和治疗疗效.

主要方法:

脂质体稳定性,大小,泽塔潜力和捕获效率的表征.
在体外评估抗原对酶降解的稳定性.
在小鼠AR模型中的体内研究评估了免疫细胞反应,基因表达,表观遗传修饰和AR症状改善.

主要成果:

该SpaCBA-OVA脂质体表现出极好的稳定性,增强的蛋白质分解性抵抗性,以及由树突细胞 (DCs) 有效吸收.
脂质细胞治疗诱导了一种半成熟的DC表型,促进IL-10和TGF-β的分泌,并将T细胞重新编程到具有FOXP3促进物脱甲基化的Treg特征.
在AR小鼠中,脂质体显著降低了AR症状,鼻异osinophils和上皮透性,同时恢复了屏障功能.

结论:

SpaCBA-OVA脂质组通过增强粘膜传递和抗原的稳定性,有效地克服了当前AIT的局限性.
这种配方重编程DC以通过代谢和表观遗传途径诱导Treg介导的耐受性,为AR提供了有前途的向治疗.

关键词:

这就是SpaCBA-OVA脂质体.这是Treg极化.过敏性鼻炎过敏性鼻炎树突细胞是一种树突细胞.粘膜免疫调节粘膜免疫调节

更多相关视频

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation

Published on: July 23, 2012

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Special Features of Adaptive Immunity

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...